Cellebrite Di Ltd. - (CLBT) closed at $12.70 on November 11, 2026, up 0.5% from the previous close, on volume of 2,791,718 shares (30-day average 1,670,829).
Data as of November 11, 2026.
11-Nov-2026
| # | Date | Strategy | Legs | Contracts |
|---|---|---|---|---|
| 1 | Nov 10, 2026 | Call Butterfly | 15-Jan-2712.5 : 15[2x] : 17.5 C | 20,000 |
| 2-3 | The next 2 largest trades are for Premium members. Start a 7-day free trial | |||
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 11, 2026. See the 10 largest for 30, 60 and 90 days
Cellebrite Reports Third-Quarter 2026 Results
TipRanks (Thu, 12-Nov 8:54 AM ET)
Cellebrite GAAP EPS of $0.10 beats by $0.02, revenue of $149.02M beats by $3.13M
Seeking Alpha News (Thu, 12-Nov 7:09 AM ET)
Cellebrite Reports Third-Quarter 2026 Results
PRNewswire (Thu, 12-Nov 7:00 AM ET)
Here are the major earnings before the open Thursday
Seeking Alpha News (Wed, 11-Nov 6:00 PM ET)
Cellebrite Q3 2026 Earnings Preview
Seeking Alpha News (Wed, 11-Nov 11:03 AM ET)
Cellebrite to Report Third-Quarter 2026 Financial Results on November 12, 2026
PRNewswire (Mon, 9-Nov 8:30 AM ET)
Cellebrite Appoints Rogerio Rizzi Executive Vice President of Corporate Strategy and Development
PRNewswire (Thu, 5-Nov 8:30 AM ET)
PRNewswire (Wed, 21-Oct 8:31 AM ET)
PRNewswire (Thu, 15-Oct 10:02 AM ET)
Newsfile (Thu, 8-Oct 4:10 PM ET)
Cellebrite DI Ltd provides AI-powered digital investigative and intelligence solutions that help public and private sector customers transform investigative workflows, make digital data more accessible and actionable, and improve the efficiency of mobile research and application security. Its solutions support law enforcement, defense, and intelligence agencies in advancing investigations, border security, counterterrorism, intelligence operations, and cyber operations. The company's software also enables enterprises and service providers to collect and review data for corporate investigations, eDiscovery, incident response, and mobile application validation. It operates in the Americas, APAC, and EMEA, with the majority of revenue from the Americas.
Cellebrite Di Ltd. - trades on the NASDAQ stock market under the symbol CLBT.
As of November 11, 2026, CLBT stock price climbed to $12.70 with 2,791,718 million shares trading.
CLBT has a beta of 0.84, meaning it tends to be less sensitive to market movements. CLBT has a correlation of 0.02 to the broad based SPY ETF.
CLBT has a market cap of $3.04 billion. This is considered a Mid Cap stock.
Last quarter Cellebrite Di Ltd. - reported $131 million in Revenue and $.11 earnings per share. This fell short of revenue expectation by $-934,488 and met earnings estimates .
In the last 3 years, CLBT traded as high as $26.30 and as low as $7.32.
The top ETF exchange traded funds that CLBT belongs to (by Net Assets): IEFA, SCZ, WCLD, EIS, SMLF.
CLBT has underperformed the market in the last year with a return of -19.1%, while the SPY ETF gained +12.4%. In the last 3 month period, CLBT fell short of the market, returning -20.8%, while SPY returned -1.1%. However, in the most recent 2 weeks CLBT has outperformed the stock market by returning +6.5%, while SPY returned -1.6%.
CLBT support price is $12.31 and resistance is $12.97 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CLBT shares will trade within this expected range on the day.
